Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wolfgang Sperr & Peter Valent. (2007) Biology and clinical features of myeloid neoplasms with inv(3) (q21q26) or t(3;3) (q21q26). Leukemia & Lymphoma 48:11, pages 2096-2097.
Read now
Read now
Articles from other publishers (13)
Barbara J. Bain. 2017. Leukaemia Diagnosis. Leukaemia Diagnosis
135
248
.
Carmen Baldazzi, Simona Luatti, Elisa Zuffa, Cristina Papayannidis, Emanuela Ottaviani, Giulia Marzocchi, Gaia Ameli, Maria Antonella Bardi, Laura Bonaldi, Rossella Paolini, Carmela Gurrieri, Gian Matteo Rigolin, Antonio Cuneo, Giovanni Martinelli, Michele Cavo & Nicoletta Testoni. (2016)
Complex chromosomal rearrangements leading to
MECOM
overexpression are recurrent in myeloid malignancies with various 3q abnormalities
. Genes, Chromosomes and Cancer 55:4, pages 375-388.
Crossref
Crossref
Marc De Braekeleer, Marie-Josée Le Bris, Etienne De Braekeleer, Audrey Basinko, Frédéric Morel & Nathalie Douet-Guilbert. (2015)
3q26/
EVI1
rearrangements in myeloid hemopathies: a cytogenetic review
. Future Oncology 11:11, pages 1675-1686.
Crossref
Crossref
Marc De Braekeleer, Nadia Guéganic, Corine Tous, Marie-Josée Le Bris, Audrey Basinko, Frédéric Morel & Nathalie Douet-Guilbert. (2015) Breakpoint heterogeneity in (2;3)(p15–23;q26) translocations involving EVI1 in myeloid hemopathies. Blood Cells, Molecules, and Diseases 54:2, pages 160-163.
Crossref
Crossref
Hyejin LeeChihyun ChoMin-Jung KwonMyung-Hyun NamChang Kyu LeeYoung Kee Kim. (2011) A Case of Concomitant Inv(3)(q21q26) and Cryptic BCR/ABL1 Rearrangement in the Blast Crisis of Chronic Myeloid Leukemia. Laboratory Medicine Online 1:3, pages 163.
Crossref
Crossref
Sun Ah Lee, Jihyang Lim, Myungshin Kim, Yonggoo Kim & Kyungja Han. (2010) A Case of t(3;3)(q21;q26.2) Associated with Severe Multilineage Dysplasia and Multi-drug Resistance in Blastic Crisis of Chronic Myelogenous Leukemia. Annals of Laboratory Medicine 30:6, pages 595-599.
Crossref
Crossref
Barbara J. Bain. 2010. Leukaemia Diagnosis. Leukaemia Diagnosis
114
218
.
P. Bernasconi, I. Dambruoso, P. M. Cavigliano, M. Boni, E. Travaglino, C. Benatti & R. Invernizzi. (2007) A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. Annals of Hematology 87:2, pages 147-150.
Crossref
Crossref
Scott A. Tomlins, Bharathi Laxman, Saravana M. Dhanasekaran, Beth E. Helgeson, Xuhong Cao, David S. Morris, Anjana Menon, Xiaojun Jing, Qi Cao, Bo Han, Jindan Yu, Lei Wang, James E. Montie, Mark A. Rubin, Kenneth J. Pienta, Diane Roulston, Rajal B. Shah, Sooryanarayana Varambally, Rohit Mehra & Arul M. Chinnaiyan. (2007) Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448:7153, pages 595-599.
Crossref
Crossref
Mireia Camós & Dolors Colomer. (2006) Molecular biology in acute leukemia. Clinical and Translational Oncology 8:8, pages 550-559.
Crossref
Crossref
Idoya Lahortiga, Iria Vázquez, Xabier Agirre, María J. Larrayoz, José L. Vizmanos, Alessandro Gozzetti, María J. Calasanz & María D. Odero. (2004) Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes, Chromosomes and Cancer 40:3, pages 179-189.
Crossref
Crossref
Idoya Lahortiga, Xabier Agirre, Elena Belloni, Iria Vázquez, María J Larrayoz, Patrizia Gasparini, Francesco Lo Coco, Pier Giuseppe Pelicci, María J Calasanz & María D Odero. (2004) Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells. Oncogene 23:1, pages 311-316.
Crossref
Crossref
Ágnes Zvara, László Hackler, B. Zsolt Nagy, Tamás Micsik & László G. Puskás. (2002) New molecular methods for classification, diagnosis and therapy prediction of hematological malignancies. Pathology & Oncology Research 8:4, pages 231-240.
Crossref
Crossref